Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Discuss Third Quarter 2012 Results of Operations on Wednesday, February 15, 2012

NORTHVALE, N.J., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
January 26, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Hydromorphone

NORTHVALE, N.J., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that on January 23, 2012, the U.S. Food and Drug Administration approved the...
January 17, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces First Shipment to ThePharmaNetwork

NORTHVALE, N.J., Jan. 17, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that the initial shipment of methadone hydrochloride 10 mg tablets has been made...
January 03, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Secures $5 Million Funding Commitment

NORTHVALE, N.J., Jan. 3, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has entered into a securities purchase agreement with Socius CG II, Ltd., a...
November 14, 2011 16:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal 2012

NORTHVALE, N.J., Nov. 14, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
November 10, 2011 12:13 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Discuss Second Quarter 2012 Results of Operations on Tuesday, November 15, 2011

NORTHVALE, N.J., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
October 19, 2011 16:33 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Results of Annual Meeting of Stockholders

NORTHVALE, N.J., Oct. 19, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceutical, Inc.'s ("Elite" or the "Company") (OTCBB:ELTP) today announced that all resolutions proposed at the Company's October 18th...
September 27, 2011 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals and ECR Pharmaceuticals Launch Lodrane D(R) Allergy Product

NORTHVALE, N.J., Sept. 27, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceutical, Inc.'s ("Elite" or the "Company") (OTCBB:ELTP) and ECR Pharmaceuticals ("ECR"), a wholly owned subsidiary of Hi-Tech Pharmacal...
August 16, 2011 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter Ended June 30, 2011

NORTHVALE, N.J., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP),a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
August 11, 2011 07:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Discuss First Quarter 2012 Results of Operations on Tuesday, August 16, 2011

NORTHVALE, N.J., Aug. 11, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...